IntegraGen has announced today its financial results for the first half of semester 2018 with the accounts having been examined by the company’s Board of Directors on September 20, 2018.
- Sales revenue: 3.7 M€, +17% vs. H1 2017
- Significant growth in genomics services
- Operating profit: -0.5 M€, + 57% vs. H1 2017
Click here to view press release